Nikkei 225 Intelligence
2026-07-31 Sumitomo Pharma Co.,Ltd. “Supplementary materials for the first quarter financial results (IF … 続きを読む
2026-07-31 Sumitomo Pharma Co.,Ltd. “Financial Results Presentation Materials for the First Quarter of F … 続きを読む
2026-07-15 Sumitomo Pharma Co.,Ltd. “The creation of the regenerative medicine product "Amshepri&qu … 続きを読む
2026-06-19 Sumitomo Pharma Co.,Ltd. “Novo Nordisk Pharma and I have a promotional partnership underway f … 続きを読む
2026-06-16 Sumitomo Pharma Co.,Ltd. “Announcement regarding the latest data presentation on the investig … 続きを読む
2026-06-10 Sumitomo Pharma Co.,Ltd. “Regarding the patient enrollment status of the Phase 2 trial of the … 続きを読む
2026-06-02 Sumitomo Pharma Co.,Ltd. “Announcement regarding the presentation of clinical data on SMP-312 … 続きを読む
2026-06-01 Sumitomo Pharma Co.,Ltd. “Announcement of organizational changes, changes in the responsibili … 続きを読む
2026-05-29 Sumitomo Pharma Co.,Ltd. “The "Notice of Convocation of the 206th Ordinary General Meeti … 続きを読む
2026-05-22 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Results of the Third-Party Allotment of Shares … 続きを読む